Publication | Closed Access

Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants

CytokineMelanomaImmunologyCulture SupernatantsImmune Checkpoint InhibitorRenal Cell CarcinomaMalignant MelanomaImmunotherapyMedicineCell BiologyTumor MicroenvironmentCancer Research